Mark is a South African Cit­i­zen, liv­ing in the Johan­nes­burg area of the Gaut­eng Province of South Africa with exten­sive expe­ri­ence in the Med­ical Devices and Health Tech­nol­ogy Indus­try. Mark is the cur­rent owner of BRANDTECH Health­care Tech­nol­ogy Con­sult­ing cc, a Strate­gic Man­age­ment and Mar­ket Access con­sul­tancy. His expe­ri­ence includes devel­op­ing busi­ness and mar­ket access strate­gies for multi­na­tional and locally based med­ical dis­trib­u­tors, inde­pen­dent med­ical prac­ti­tioner and specialist  asso­ci­a­tions and societies, med­ical scheme admin­is­tra­tors and patient advocacy groups. Through these inter­ac­tions and activ­i­ties Mark has built exten­sive and unique expe­ri­ence and net­works that aims to ben­e­fit exist­ing and poten­tial clients.

Mark’s career in health­care spans 28 years, and before con­sult­ing spent 15 years at John­son and John­son (J&J), hold­ing var­i­ous port­fo­lios in national sales and mar­ket­ing man­age­ment in the Ethicon Endo­surgery (EES) Fran­chise, includ­ing health eco­nom­ics and reim­burse­ment (HE&R). Prior to this Mark estab­lished the first ded­i­cated HE&R Divi­sion for J&J, and probably the first in a med­ical device com­pany in South Africa, respon­si­ble for mar­ket access.

This business port­fo­lio cut across a diverse range of tech­nolo­gies, includ­ing min­i­mally inva­sive surgery, mechan­i­cal sur­gi­cal sta­pling, energy sources, infec­tion con­trol, breast care and intra­venous catheter sys­tems. At var­i­ous stages of his tenure within J&J Mark led either the mar­ket­ing or sales teams that estab­lished this busi­ness as mar­ket leader in the mar­kets served.

Expe­ri­ence through con­sult­ing now extends across spe­cial­i­ties and tech­nolo­gies used in Gas­tro Intesti­nal Ther­a­pies, Orthopaedics, Car­di­ol­ogy and Car­diac Surgery, Urol­ogy, Diagnostics and Wound Care.

Mark has been involved in the indus­try as a for­mer board mem­ber and chair of the Mar­ket Access Committee of the South African Med­ical Devices Asso­ci­a­tion (SAMED) and the Inter­na­tional Soci­ety for Pharmaco-economics and Out­comes research (ISPOR), lead­ing ini­tia­tives aimed at improv­ing access to inno­v­a­tive health care in South Africa. Mark holds a MBA in Strate­gic Mar­ket­ing, on top of aca­d­e­mic expe­ri­ence in HTA. He also has another life by enjoy­ing water sports and cycling.